Plum Catherine, Stolbrink Marie, Ozoh Obianuju, Jayasooriya Shamanthi, Nightingale Rebecca, Mortimer Kevin, Halpin David
University Hospitals of Morecambe Bay NHS Trust, Lancaster, UK
Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
Thorax. 2025 Mar 18;80(4):248-250. doi: 10.1136/thorax-2024-222391.
Smoking cessation is more effective when supported by medicines. Data on the availability, cost and affordability of these treatments in low-income and middle-income countries (LMIC) are limited. Cross-sectional data for smoking cessation medications were collected from pharmacies, healthcare facilities and central medicine stores in 60 LMIC (2022-2023). Medications had varying availability, large price ranges and were essentially unaffordable. Enabling access to these medications is important in reducing tobacco consumption and associated disease. Strategies for integrating smoking cessation services into health systems are needed to reach Sustainable Development Goal targets.
在药物支持下戒烟会更有效。关于这些治疗方法在低收入和中等收入国家（LMIC）的可获得性、成本和可负担性的数据有限。从60个低收入和中等收入国家的药店、医疗机构和中央药店收集了戒烟药物的横断面数据（2022 - 2023年）。药物的可获得性各不相同，价格范围很大，基本上难以负担。使人们能够获得这些药物对于减少烟草消费和相关疾病很重要。需要将戒烟服务纳入卫生系统的策略，以实现可持续发展目标。
